Cargando…
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
The transmembrane serine protease 2 (TMPRSS2) primes the SARS-CoV-2 Spike (S) protein for host cell entry and represents a promising target for COVID-19 therapy. Here we describe the in silico development and in vitro characterization of peptidomimetic TMPRSS2 inhibitors. Molecular docking studies i...
Autores principales: | Wettstein, Lukas, Knaff, Philip Maximilian, Kersten, Christian, Müller, Patrick, Weil, Tatjana, Conzelmann, Carina, Müller, Janis A, Brückner, Maximilian, Hoffmann, Markus, Pöhlmann, Stefan, Schirmeister, Tanja, Landfester, Katharina, Münch, Jan, Mailänder, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270327/ https://www.ncbi.nlm.nih.gov/pubmed/35804152 http://dx.doi.org/10.1038/s42003-022-03613-4 |
Ejemplares similares
-
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
por: Wettstein, Lukas, et al.
Publicado: (2021) -
Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
por: Wettstein, Lukas, et al.
Publicado: (2022) -
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures
por: Schütz, Desiree, et al.
Publicado: (2021) -
The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
por: Wettstein, Lukas, et al.
Publicado: (2022) -
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
por: Brückner, Maximilian, et al.
Publicado: (2022)